StonvexLoading…
StonvexStonvexStonvexCore line items from CALM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-06-01 | Annual 2023 2023-06-03 | Annual 2022 2022-05-28 |
|---|---|---|---|---|
Revenue | $4.26B | $2.33B | $3.15B | $1.78B |
Operating Income | $1.54B | $312.45M | $967.73M | $143.54M |
Net Income | $1.22B | $277.89M | $758.02M | $132.65M |
EPS (Diluted) | $24.95 | $5.69 | $15.52 | $2.72 |
Total Assets | $3.08B | $2.18B | $1.95B | $1.43B |
Total Liabilities | $518.60M | $387.72M | $344.94M | $323.14M |
Cash & Equivalents | $499.39M | $237.88M | $292.82M | $59.08M |
Free Cash Flow OCF − CapEx | $1.06B | $304.28M | $726.44M | $53.81M |
Shares Outstanding | 48.89M | 48.87M | 48.83M | 48.94M |